Physician

Michael David Jain, MD

According to 2025 Medicare claims, Michael Jain, MD (NPI: 1982139655) practices hematopoietic cell transplantation and cellular therapy in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (NPI: 1306833595; TIN: 593238640) and primary practice location at 33612-9416.

Jain's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 78 traditional Medicare patients, billed 242 HCPCS/CPT codes, and received $18,220 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 412 prescription claims across 66 beneficiaries totaling $361,842 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 15 records totaling $15,657. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $6,840 to $361,842. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	33	123	$10,209
2018	84	299	$25,826
2019	81	242	$18,992
2020	88	264	$22,329
2021	84	281	$26,342
2022	87	244	$21,722
2023	84	201	$18,186
2024	78	242	$18,220

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	29	$6,840
2018	38	194	$23,436
2019	33	129	$77,507
2020	42	213	$58,901
2021	44	295	$216,101
2022	61	285	$116,052
2023	69	326	$372,727
2024	66	412	$361,842

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	44	78	$112
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	59	$76
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	26	32	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	16	540	$10,550
Acyclovir	Acyclovir	128	4,590	$3,620
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	44	2,700	$615
Oxycodone Hcl	Oxycodone Hcl	14	118	$99
Ondansetron Hcl	Ondansetron Hcl	15	144	$37

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$2,186	Novartis Pharma AG
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$13,471	Moffitt Cancer Center
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Michael David Jain, MD?

Tedicare shows public-source Medicare data for Michael David Jain, MD (NPI 1982139655), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael David Jain, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael David Jain, MD?

Michael David Jain, MD is linked to H LEE MOFFITT CANCER CTR & RES INST LIFE TIME CANCER SCRN CTR INC (billing NPI 1306833595) in the available physician profile data.

Does Michael David Jain, MD have Open Payments data?

Michael David Jain, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.